| cannabidiol for epilepsy |
Daily update ⋅ August 18, 2019
Johnston Asset Management Has Upped Stake in Gw Pharmaceuticals Plc (GWPH) by $1.06 ...
Some Historical GWPH News: 19/04/2018 – FDA Advisory Panel Backs GW Pharmaceuticals' Proposed Drug for Epilepsy; 16/05/2018 – Cannabidiol ...
Gw Pharmaceuticals Plc (GWPH) Stock Declined While Sio Capital Management Trimmed Its ... - The NBO News
|See more results | Edit this alert|
|You have received this email because you have subscribed to Google Alerts.|
|Receive this alert as RSS feed|